{"url_path":"/sec/ingn/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1294133/0001294133-26-000016-index.html","accession_number":"0001294133-26-000016","cik":"0001294133","ticker":"INGN","issuer_name":"Inogen Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1294133/0001294133-26-000016-index.html","primary_entity_key":"0001294133","primary_entity_name":"Inogen Inc"},"word_count":94,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nWe are party to various legal proceedings and investigations arising in the normal course of business. We carry insurance, subject to specified deductibles under the policies, to protect against losses from certain types of legal claims. At this time, we do not anticipate that any of these other proceedings arising in the normal course of business will have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors."}